Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

12 results about "Gingival inflammation" patented technology

Gingivitis is an inflammation of the gums, usually caused by a bacterial infection. If left untreated, it can become a more serious infection known as periodontitis.

Use of ectoine or its derivatives in the prevention and / or improvement of gingival damage caused by cigarette smoke and methods for achieving this use.

This application discloses the use of ectoine or its derivatives in preventing and / or improving gingival damage caused by cigarette smoke, as well as methods for achieving this use. Ectoine or its derivatives can effectively prevent and / or improve gingival damage caused by cigarette smoke, thus expanding the scope of application of ectoine or its derivatives. Furthermore, ectoine or its derivatives can effectively prevent and / or improve gingival recession and / or gingival inflammation caused by cigarette smoke, and can be used in products such as oral care products.
Owner:BLOOMAGE BIOTECHNOLOGY CORP LTD

LGM2605 for the mitigation of pathogen-associated gingival inflammation and periodontitis

PCT designated stageWO2025128919A9Organic active ingredientsSugar derivativesGum inflammationSecoisolariciresinol diglucoside
The present disclosure provides methods of using secoisolariciresinol diglucoside (SDG) (including stereoisomers thereof), for example, a synthetic SDG such as LGM2605, to treat periodontitis, for example, molar-incisor pattern periodontitis (MIPP), and / or pathogen-associated gingival inflammation in a subject.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA

Use of oligopeptide in treatment of gingival inflammation, gingival atrophy and oral mucosa repair

The present invention relates to a method for treating gingivitis and gingival atrophy and repairing oral mucosa in a subject, comprising a step of administering to the subject a therapeutically effective amount of an oligopeptide of the formula (I):         X1X2X3X4X5X6     (I) wherein X1 is glycine (Gly; G) or lysine (Lys; K); X2 is glutamic acid (Glu; E) or threonine (Thr; T); X3 is K or T; X4 is G or K; X5 is serine (Ser; S), phenylalanine (Phe; F) or absent; and X6 is F or absent.
Owner:CHUANG KO SHENG

Lactobacillus rhamnosus for improving oral health as well as product and application thereof

The invention discloses a lactobacillus rhamnosus for improving oral health as well as a product and application thereof, and belongs to the technical field of microorganisms. The invention aims to solve the technical problems that the existing strain is insufficient in targeting to core problems such as inhibition of oral volatile sulfur compounds (VSCs) and relieving of gingival inflammation, and is poor in adaptability to oral care products, and traditional chemical products also have side effects such as mucous membrane stimulation. The key points of the technical scheme are as follows: the lactobacillus rhamnosus MH-LR13 (preservation number is CGMCC No.37262) is provided, can specifically inhibit VSCs producing bacteria and pathogenic bacteria related to gingival inflammation, and is excellent in oral planting capacity; the application of the composition in products for improving oral health is protected, and the core effect is defined; the invention provides a composition containing the bacterial strain, an oral cavity refreshing spray and an adaptive preparation process, the product is high in safety and obviously superior to the existing bacterial strain and a commercially available product in effect through experimental verification of people, and a natural and mild long-acting solution is provided for oral health.
Owner:TIANJIN UNIV OF SCI & TECH +1

An antibacterial agent against periodontal disease-related bacteria and dental caries-related bacteria, a composition for preventing and treating periodontal disease, a composition for preventing and treating dental caries, a composition for improving gingiva, a composition for improving gums, a composition for suppressing plaque accumulation, a composition for improving xerostomia, a composition for improving saliva, a composition for suppressing halitosis, and a composition for improving constipation.

PendingJP2026020356ACosmetic preparationsAntibacterial agentsBleeding gumDrying mouth
To provide a composition capable of exhibiting new effects of bay laurel (LaurusnobilisL.).SOLUTION: The composition contains an extract of bay laurel (LaurusnobilisL.), has an antibacterial action against Tannerellaforsythensis and Streptococcusmutans, suppresses gingival inflammation, spontaneous bleeding of gums and plaque accumulation, improves dryness in the oral cavity and saliva pH, suppresses halitosis and improves constipation. Specifically, the present invention relates to an antibacterial agent against periodontal disease-related bacteria and dental caries-related bacteria, a composition for preventing or treating periodontal disease, a composition for preventing or treating dental caries, a composition for improving gingiva, a composition for improving gums, a composition for suppressing plaque (dental plaque) accumulation, a composition for improving xerostomia, a composition for improving saliva, a composition for suppressing halitosis, and a composition for improving constipation, each of which contains a bay laurel (LaurusnobilisL.) extract as an active ingredient. By containing the bay laurel (LaurusnobilisL.) extract, it is possible to suppress Tannerellaforsythensis and Streptococcusmutans which are periodontal disease-related bacteria, suppress gingival inflammation, spontaneous bleeding of gums, and plaque accumulation, improve dryness in the oral cavity and saliva pH, suppress halitosis, and improve constipation.SELECTED DRAWING: None
Owner:TOKIWA PHYTOCHEM CO LTD

Treatment for gingivitis

PendingUS20260137717A1Cosmetic preparationsAntibacterial agentsOral diseaseChronic gingivitis
The present invention relates to compositions and their use for oral care. In particular, the compositions and methods are for maintaining oral health and / or treating various oral conditions such as gingivitis. The present invention relates to methods and uses of stabilized amorphous calcium phosphate (ACP) and / or stabilized amorphous calcium fluoride phosphate (ACFP) in the preparation of a medicament for reducing pathogenic oral bacteria at an oral site in an individual; increasing commensal oral bacteria at an oral site in an individual; decreasing the proportion of pathogenic oral bacteria at an oral site in an individual; inhibiting oral dysbiosis; reducing gingival inflammation in an individual in need thereof; treating gingivitis in an individual in need thereof; and treating chronic gingivitis in an individual in need thereof.
Owner:UNIVERSITY OF MELBOURNE

Application of recombinant human glaze matrix protein in anti-periodontitis oral care product

PendingCN122075334ACosmetic preparationsAntibacterial agentsPeriodontal pathogenToothpaste
The invention discloses application of recombinant human glaze matrix protein in preparation of an anti-periodontitis oral care product. The oral care product is prepared from rhEMPs, glycerin, sorbitol, poloxamer 188, sodium lauroyl sarcosinate, potassium nitrate, sucralose, xylitol, methylparaben, propylene glycol, PEG-40 hydrogenated castor oil, domiphen and water. The core innovation of the oral care product is that the stability bottleneck of rhEMPs in the physiological pH environment of the oral care product is solved by utilizing the synergistic stabilization effect of poloxamer 188 and sodium lauroyl sarcosinate, and it is found that when the oral care product is combined with components such as potassium nitrate, periodontal pathogenic bacteria can be remarkably inhibited, gingival inflammation can be relieved, and periodontal tissue repair can be promoted. The product form can be mouth wash, oral spray or toothpaste, the preparation process is simple, the stability is good, and a brand new solution is provided for daily adjuvant therapy of periodontitis.
Owner:GUANGZHOU XUELIANG BIOTECHNOLOGY DEVELOPING CO LTD

Ingestible Oral Care Compositions and Uses Thereof

The present disclosure relates to ingestible oral care compositions and their use, for example, to control dental plaque and / or gingival inflammation in a subject. For example, the ingestible oral care composition may include: proteins, lipids, polysaccharides and / or derivatives thereof, and optionally active agents, in a water-based, orally acceptable vehicle.
Owner:EDICCARE INC

Glycyrrhiza source fluorescent carbon quantum dots and preparation method and application thereof

The application discloses licorice source fluorescent carbon quantum dots and a preparation method and application thereof, and the preparation method comprises the following steps: crushing dried licorice root stems, adding water in a proportion of 100 mg to (10-20) mL, carrying out hydrothermal reaction at 140-180 DEG C for 5-6 h, filtering through a 0.22 mu m microporous filter after centrifugation, and obtaining a brown-yellow carbon quantum dot aqueous solution with special fragrance and fluorescent characteristics, which is the licorice source fluorescent carbon quantum dots. Compared with a traditional method of extracting licorice extraction liquid, the licorice source fluorescent carbon quantum dots can not only achieve significant inhibition of growth of Porphyromonas gingivalis and Staphylococcus aureus at a low concentration, but also have significant fluorescent characteristics, can realize real-time visualization of a treatment area visible to the naked eye under excitation of common handheld ultraviolet light or blue light sources, thereby improving administration accuracy, and significantly reducing plaque aggregation on a tooth surface and inhibiting gingival inflammation.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Negative-pressure siphon bacteriostatic electric toothbrush head

PendingCN121606403ATooth cleaningPorphyromonas gingivalisBristle
The invention discloses a negative-pressure siphon bacteriostatic electric toothbrush head, which belongs to the technical field of electric toothbrushes and comprises a toothbrush handle and a toothbrush head detachably connected to the toothbrush handle. The toothbrush head comprises a storage seat, cleaning bristles, a connecting insertion rod and an outer shell; the outer shell is detachably installed on the back face of the storage base, the cleaning bristles are installed on the front face of the storage base, the connecting insertion rod is installed at the bottom of the storage base, the toothbrush further comprises a sealed negative pressure mechanism, and the sealed negative pressure mechanism is located in the toothbrush handle and extends into the storage base. A detachable back cover is arranged on the back of the storage seat, and an air bag puncturing structure is arranged on the back cover. According to the electric toothbrush, bacteriostatic active substances are accurately conveyed to a clean area through a negative pressure siphon mechanism, breeding of harmful bacteria such as streptococcus mutans and porphyromonas gingivalis is inhibited from the source, tooth enamel corrosion and gingival inflammation caused by acidic substances are avoided, and the functional blank that a traditional electric toothbrush cannot inhibit bacteria is filled.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

BTO / PB acoustic pressure electrocatalytic nanoplatform ointment, its preparation method and application

PendingCN122075688Agood biocompatibilityNo risk of drug resistanceCosmetic preparationsHeavy metal active ingredientsPeriodontal pathogenInflammatory factors
This invention relates to the field of biopharmaceutical technology, specifically to a BTO / PB acoustic pressure electrocatalytic nanoplatform ointment, its preparation method, and its application. The ointment is an injectable BTO / PB acoustic pressure electrocatalytic nanoplatform ointment formed by combining a barium titanate and Prussian blue composite nanomaterial with an ointment. The BTO / PB acoustic pressure electrocatalytic nanoplatform ointment of this invention exhibits excellent biocompatibility. Unlike traditional antibiotics, BTO / PB generates ROS (reactive oxygen species) through an ultrasound-driven catalytic reaction, independent of antibiotics, thus eliminating the risk of drug resistance. It effectively addresses the increasingly serious problem of antibiotic resistance, has a good antibacterial effect against periodontal pathogens, significantly alleviates gingival inflammation, reduces the infiltration of inflammatory cells, lowers the expression of inflammatory factors, and effectively inhibits osteoclast activity, thereby protecting alveolar bone and maintaining the integrity of periodontal tissues.
Owner:HUBEI UNIV

Gum massager

The utility model discloses a kind of gum massagers, mainly applied to physiotherapy apparatus technical field, contain button type latch, knurled bolt, screw rod, spring, eccentric wheel motor, neck ring, neck support, cross arm, boss, strut, screw rod seat, massage head, the neck ring is semicircular ring structure, inner wall edge is connected with neck support, the neck ring both ends extend downward, and the extension one end is rotatably connected with cross arm, the other end has button type latch, for locking or opening the other end of cross arm, the boss is vertically connected with the center of cross arm, the one end of strut is rotatably connected with boss, and knurled bolt is connected, the top end of strut has internal thread, and the screw rod is engaged with internal thread. Application the utility model of a kind of gum massager, it is convenient and fast to use, man-machine engineering is excellent, use is more comfortable, sanitary clean, can be used as household physiotherapy product, utilization is higher, manufacturing cost is low, physiotherapy effect is better, effectively prevent the occurrence of gingival atrophy and gingival inflammation.
Owner:李继明